Lonza shells out $107M cash to snap up Synaffix and its ADC platform

Amber Tong

After lining up a string of partnerships over the years, Dutch antibody-drug conjugate specialist Synaffix has found a new home: Lonza, the contract development and …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Lonza shells out $107M cash to snap up Synaffix and its ADC platform

Amber Tong

Sign up to read this article for free.

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

Trump’s science crackdown hits rare disease medicine: ‘We need to sit down with Elon Musk’

Lilly joins molecular glue field with Magnet deal worth up to $1.25B

Pfizer vet William Pao’s next venture; Sanofi’s computational science exec leaves

Can Bill Anderson save Bayer?

Pharma-backed Mission Therapeutics stops preclinical operations, focuses on two clinical assets

How AI can address ongoing challenges in the life sciences industry

Lon­za shells out $107M cash to snap up Synaf­fix and its ADC plat­form

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

Lonza shells out $107M cash to snap up Synaffix and its ADC platform